Literature DB >> 6506081

A model system for measuring comparative toxicities of cardiotoxic drugs for cultured rat heart myocytes, endothelial cells and fibroblasts. II. Doxorubicin, 5-fluorouracil and cyclophosphamide.

D G Wenzel, G N Cosma.   

Abstract

Separate cultures of beating myocytes (M cells), endothelial cells (E cells) and fibroblasts (F cells) from neonatal rat hearts were compared for their susceptibilities to the toxic effects of doxorubicin, 5-fluorouracil and cyclophosphamide. Toxic injury was measured as inhibition of metabolism and changes in morphology for all cell types, and changes in beating of myocytes. Cells were exposed to the anti-tumor agents for 3 days with myocytes and 7 days for endothelial cells and fibroblasts. All measures of injury were made several times the first day and daily thereafter, with the same cultures used throughout. Toxic effects of DOX and 5-FU were greater for E and F cells than for M cells, and all measures of toxicity were generally parallel. Cyclophosphamide, whether activated by liver microsomes or unactivated, was less toxic in general than the other agents, but it was more toxic for M cells than for E cells or F cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6506081     DOI: 10.1016/0300-483x(84)90067-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  7 in total

Review 1.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

2.  Anthracycline cardiotoxicity: from bench to bedside.

Authors:  Luca Gianni; Eugene H Herman; Steven E Lipshultz; Giorgio Minotti; Narine Sarvazyan; Douglas B Sawyer
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

3.  Aortic stiffness increases upon receipt of anthracycline chemotherapy.

Authors:  Narumol Chaosuwannakit; Ralph D'Agostino; Craig A Hamilton; Kimberly S Lane; William O Ntim; Julia Lawrence; Susan A Melin; Leslie R Ellis; Frank M Torti; William C Little; W Gregory Hundley
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

4.  5-Fluorouracil-induced acute reversible heart failure not explained by coronary spasms, myocarditis or takotsubo: lessons from MRI.

Authors:  Yama Fakhri; Morten Dalsgaard; Dorte Nielsen; Per Lav Madsen
Journal:  BMJ Case Rep       Date:  2016-06-01

Review 5.  A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.

Authors:  Anne Polk; Kirsten Vistisen; Merete Vaage-Nilsen; Dorte L Nielsen
Journal:  BMC Pharmacol Toxicol       Date:  2014-09-04       Impact factor: 2.483

6.  Gel with silver and ultrasmall iron oxide nanoparticles produced with Amanita muscaria extract: physicochemical characterization, microstructure analysis and anticancer properties.

Authors:  Olena Ivashchenko; Łucja Przysiecka; Barbara Peplińska; Marcin Jarek; Emerson Coy; Stefan Jurga
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

7.  Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy.

Authors:  Treya M Long; Channa E Marsh; Lawrence G Dembo; Philip Watson; Karen E Wallman; Thomas S Walwyn; Catherine S Choong; Louise H Naylor
Journal:  Cardiooncology       Date:  2019-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.